Pharma Journalist -

Clinigen Group plc has launched a Managed Access Program for Progenics Pharmaceuticals, Inc., an oncology company developing innovative targeted medicines and artificial intelligence to…
Read More...

VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived…
Read More...

Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated, announced it has entered into a global licensing agreement with Janssen Pharmaceutica NV and…
Read More...

Advaxis, Inc. announced a research collaboration agreement with the University of California Los Angeles (UCLA) to conduct preclinical studies evaluating the Company’s Lm technology in…
Read More...

CURE Pharmaceutical, an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line creating CUREform which includes CUREfilm, one…
Read More...

Adaptimmune Therapeutics plc and Cryoport, Inc. announce a 3-year agreement to ensure safe and fully monitored transport of Adaptimmune’s cell therapies. Optimizing manufacturing and…
Read More...

Ionis Pharmaceuticals, Inc. announced that the company has been notified by its partner Bayer about the decision to advance IONIS-FXI-LRx following positive clinical results.…
Read More...

bluebird bio, Inc. and Novo Nordisk A/S (NVO) announced that they have entered into a research collaboration to jointly develop next-generation in vivo genome editing treatments for…
Read More...

Viela Bio, Inc. and Mitsubishi Tanabe Pharma Corporation announced a collaboration focused on the development and commercialization of inebilizumab – Viela’s humanized anti-CD19…
Read More...

Alcami Corporation announced the launch of its new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster…
Read More...